Table 1.
Demographics and clinical variables of hepatocellular carcinoma patients.
| Variable | Total (n=178) | ||
|---|---|---|---|
| Age | 59.5 | (31–80) | |
| Gender | Female | 28 | (15.7) |
| Male | 150 | (84.3) | |
| Cause | Hepatitis B virus | 133 | (74.7) |
| Hepatitis C virus | 15 | (8.4) | |
| Alcoholic liver disease | 21 | (11.8) | |
| Autoimmune liver disease | 2 | (1.1) | |
| Type | Diffuse | 13 | (7.3) |
| Massive | 42 | (23.6) | |
| Massive + diffuse | 1 | (0.6) | |
| Massive + nodular | 2 | (1.1) | |
| Nodular | 101 | (56.7) | |
| Simple nodular | 19 | (10.7) | |
| Metastasis | Yes | 25 | (14.0) |
| No | 152 | (85.4) | |
| Stage | I | 18 | (10.1) |
| II | 50 | (28.1) | |
| III | 50 | (28.1) | |
| IV-A | 34 | (19.1) | |
| IV-B | 25 | (14.0) | |
| Size (cm) | <5 | 101 | (56.7) |
| ≥5 | 75 | (42.1) | |
| PVT | Negative | 115 | (64.6) |
| Positive | 62 | (34.8) | |
| Albumin (g/dL) | 3.5 | (1.7–5.1) | |
| AST (U/L) | 65.5 | (21–923) | |
| ALT (U/L) | 40 | (5–654) | |
Age, albumin, AST and ALT are shown as median (range); Gender, type, metastasis, stage, size, PVT (portal vein thrombosis) are shown as frequency (percentage).